Our LeadershipMeet the Team Powering Likarda, Inc.

At the heart of Likarda is a team of seasoned leaders and scientists harnessing decades of industry experience to turn cutting-edge cell and hydrogel technologies into real-world therapeutic advances.

Circular line illustrations highlighting the Likarda team working in a lab.
Dr. Stella Vnook

Dr Stella Vnook

CEO

With 25+ years in pharma leadership, Stella steers our strategic vision.

Lisa Stehno-Bittel, PhD

Lisa Stehno-Bittel, PhD

President & Founder

A pioneer in cell biology with 20+ years in translational science and business.

Jason Maidment, MBA

Jason Maidment, MBA

CFO

Veteran of M&A and IPO execution—over 20 years in biotech finance.

Shelly Adams

Shelly Adams

Chief Commercial Officer

A biotech commercial expert driving partner success across GLP and GMP programs.

Stephen Harrington, PhD

Dr. Stephen Harrington

Director, Cell & Hydrogel Formulation

Inventor of CSS®, certified Six Sigma bioengineer.

Francis Karanu, PhD

Dr. Francis Karanu

Director, Cell Therapy R&D

Brings 22+ years in stem cell biology with a focus on metabolic applications.

Jordan Hunt. Ph.D

Dr. Jordan Hunt

Head of Product Innovation

Formulation expert versed in API stability and dosage design.

Donald Muathe, MSc

Donald Muathe, MSc

Director of Quality Control

Ensures quality, compliance, and manufacturing precision.

Why Our Team Stands Out

Together, our leadership blends cross-functional R&D, commercial execution, and regulatory rigor—creating a powerful engine for translating your molecule or cell therapy from concept into scalable, market-ready platforms.

Two conversation bubbles.

Next Step

Ready to explore how our team can support your goals? Book a call with a scientist to build a customized plan for your program.